Merck Sharp & Dohme have
issued a within 48 hour pharmacy
level recall in the UK of Cosopt
(dorzolamide / timolol) eye drops
for two batch numbers: MK13D002
and MK13D004.
The recall is due to an increase
in the number of adverse events
and product complaints relating
to difficulties with administration
received following the introduction
of the ‘winged’ presentation in July
last year.The above article was sent to subscribers in Pharmacy Daily's issue from 19 Feb 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Feb 14
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.